Neurol. praxi. 2010;11(2):107-111

Neuropatic pain in diabetic neuropathy

doc.MUDr.Edvard Ehler, CSc.
Neurologická klinika, Pardubická krajská nemocnice, a.s., Pardubice

Diabetic neuropathy may be associated with neuropathic pain. Type, intensity and localization of pain differ according to the type of

neuropathy or the pathophysiology of neuropathic pain. In treatment of diabetic neuropathy and following neuropathic pain there is

necessary to compensate diabetes and associated metabolic abnormalities. On the basis of many randomized clinical trials there was

proved effectivity on neuropathic pain in diabetic neuropathy for tricyclic antidepressants, gabapentin/pregabalin, serotonin-noradrenalin-

reuptake inhibitors and opioids. Monotherapy is successful in 30–40 % of patients, but the most patients should be treated by

combined therapy.

Keywords: diabetic neuropathy, neuropathic pain, pain relief, pharmacological treatment

Published: April 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ehler E. Neuropatic pain in diabetic neuropathy. Neurol. praxi. 2010;11(2):107-111.
Download citation

References

  1. Ambler Z, Bednařík J, Keller O. Doporučený postup pro léčbu neuropatické bolesti. Čes Slov Neurol Neurochir 2002; 65(98): 135-138.
  2. Attal N, Cruccu G, Haanpaa, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006; 13: 1153-1169. Go to original source... Go to PubMed...
  3. Backonja MM, Irving G, Argoff C. Rational multidrug therapy in the treatment of neuropathic pain. Curr Pain Headache Rep 2006; 10: 34-38. Go to original source... Go to PubMed...
  4. Cruccu G. Treatment of painful neuropathy. Curr Opin Neurol 2007; 20: 531-535. Go to original source... Go to PubMed...
  5. Daousi C, MacFarlane IA, Woodward A, Nurmikko TH, Bundred PE, Benbow SJ. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med 2004; 21: 976-982. Go to original source... Go to PubMed...
  6. Dyck PJB, Sinnreich M. Diabeti neuropathies. Continuum 2003; 9: 19-34.
  7. Moravcová E, Bednařík J. Diabetická neuropatie. Neurol. pro praxi 2006; 7(2): 99-103.
  8. Scadding JW, Koltzenburg M. Painful peripheral neuropathies. In: McMahon SB, Koltzenburg M (eds.) Walla and Melzacks´s Textbook of pain. 5th edition. Philadelphia Elsevier, 2006: 973-1000. Go to original source...
  9. Sills GJ. The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol 2006; 6: 108-113. Go to original source... Go to PubMed...
  10. Thomas PK. Mechanisms and treatment of pain. In: Dyck JP, Thomas PK (eds.) Diabetic neuropathy. 2nd edition. Philadelphia WB Saunders Comp 1999: 387-397.
  11. Vondrová H. Léčba diabetické polyneuropatie. Neurol. pro praxi 2008; 9(4): 245-248.
  12. Ziegler D. Thioctic acid for patients with symptomatick diabeti neuropathy: a critical review. Trat endocrinol 2004; 3: 1-17. Go to original source... Go to PubMed...
  13. Ziegler D. Treatment of diabetic neuropathy and neuropathic pain. Diabetes care 2008; 31(Suppl.2): S255-262. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.